ACE Report Cover
Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descarregar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
OSTEOARTHRITIS
Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2015;3(6):29 Acta Orthop. 2014 Dec;85(6):556-61.
Autores contribuintes

E Weber M Sundberg G Flivik

50 patients with primary osteoarthritis undergoing total hip arthroplasty were randomized to receive either the Furlong Active femoral stem or the traditional Furlong HAC femoral stem. The purpose of this study was to evaluate the 3-D migratory patterns of the two stems using radiostereometry. Results after 3 months demonstrated significantly greater subsidence of the Furlong Active stem compared to the Furlong HAC stem, though subsidence of each stem plateaued after 3 months and displayed minor changes through to 5 years. Both groups displayed initial retroversion of the implant at 3 months, though minimal differences through to 5 years thereafter. Clinical outcome significantly improved in both groups over 5 years, with no significant differences detected between groups at 1, 2, or 5 year follow-up.


Detalhes do financiamento da publicação +
Financiamento:
Industry funded
Patrocinador:
JRI Ltd.
Conflitos:
None disclosed

Risco de viés

6,5/10

Critérios de notificação

14/20

Índice de Fragilidade

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sim = 1

Incerto = 0,5

Não relevante = 0

Não = 0

A Avaliação dos Critérios de Relato avalia a transparência com que os autores relatam as caraterísticas metodológicas e do ensaio na publicação. A avaliação está dividida em cinco categorias que são apresentadas de seguida.

1/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

3/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

O Índice de Fragilidade é uma ferramenta que auxilia na interpretação de achados significativos, fornecendo uma medida de força para um resultado. O Índice de Fragilidade representa o número de eventos consecutivos que precisam de ser adicionados a um resultado dicotómico para que o resultado deixe de ser significativo. Um número pequeno representa um resultado mais fraco e um número grande representa um resultado mais forte.

Porque é que este estudo era necessário agora?

The Furlong HAC stem is a well-proven femoral implant that has recently undergone modifications to the lateral fin to prevent fracture of the greater trochanter during insertion. The new stem - the Furlong Active stem - is a shorter cone-shape, double-tapered, and has more rounded medial and lateral edges. Using radiostereometry, this study aimed to compare the migratory patterns of the Furlong HAC and Furlong Active stem as a surrogate for osseointegration and long-term survival of the arthroplasty.

Qual era a principal questão de investigação?

Do design modifications to the Furlong HAC stem to give the Furlong Active stem affect the migratory behaviour, osseointegration and long-term result of total hip arthroplasty up to 5 years after surgery?

Caraterísticas do estudo +
População:
50 patients (mean age: 63 years, mean BMI: 27, 27M/23F) with primary osteoarthritis scheduled for total hip arthroplasty. Patients who had unstable femoral anatomy as determined by radiographs and who were Charnley category C patients were excluded from the study. 45 patients (23M/20F) completed the study to completion at the 5 year endpoint. Surgery for both groups was performed using a posterolateral approach and 8-10 tantalum bone markers (diameter=0.8 mm). Apart from the femoral head used as a marker, all prostheses were pre-marked with tantalum markers at the tip, shoulder and medial collar of the stem.
Intervenção:
Furlong Active group: Participants received the Furlong Active stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 9M/16F) (Mean age: 62 years, range: 50-77 years)
Comparação:
Furlong HAC group: Participants received the Furlong HAC stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 18M/7F) (Mean age: 63 years, range: 49-75 years)
Resultados:
Radiostereometry (RSA) and conventional radiographic examinations were performed to analyze motion of the stem in relation to the tantalum markers implanted in the femur. Stem subsidence (Y-translation) and retroversion (Y-rotation) were primary effect variables. Self-administered Hip Disability and Osteoarthritis Outcome Score (HOOS) was also assessed.
Métodos:
RCT: Single-centre
Tempo:
Radiostereometry (RSA) and conventional radiographic examinations were conducted on the first postoperative day, before weight-bearing and then at 3 months, 1,2 and 5 years (+/-5% time tolerance) postoperatively. Routine clinical follow-up occurred 3 months and 1, 2 and 5 months postoperatively. Hip Disability and Osteoarthritis Outcome Score was evaluated prior to surgery and at 1, 2 and 5 years.
Quais foram os resultados importantes?
  • Significantly greater subsidence of the implant was noted in the Furlong Active group (0.99mm distally) compared to the Furlong HAC group (0.31mm distally) (p=0.0.46). Subsequent subsidence from 3 months to 5 years was not statistically significant in the Furlong Active (p=0.5) or HAC (p=0.06) stem.
  • There was one case of extreme subsidence reported in the Furlong Active group (6.5mm after 3 months) in a patient with BMI 41. Exclusion of this outlier case from the main analysis resulted in a non-significant difference in subsidence between groups (p>0.05).
  • Mean retroversion of the femoral stem was measured at 1.18deg in the Furlong Active group and 0.80deg in the Furlong HAC group after 3 months; the difference between groups was not statistically significant. (p=0.46). From 3 month to 5 years, no significant changes in mean retroversion were noted in either the Furlong Active (p=0.1) or HAC group (p=0.1).
  • Two patients, one in the Furlong HAC group (4.2 degrees) and one in the Furlong Active group (5.1 degree), demonstrated significant retroversion of the stem within the first 3 months after surgery. Between 3 months and 5 years, no further retroversion was noted in either patient.
  • No stem in either group was judged to be loose over the 5 year follow-up period.
  • HOOS scores improved significantly within both groups, without significant difference between groups at 1, 2, or 5 years after surgery.
  • Minor X- and Z-plane translation and rotation of the stem were noted in both groups, and differences were small between groups.
De que é que me devo lembrar mais?

In total hip arthroplasty, subsidence of the uncemented Furlong Active femoral stem was significantly greater than the Furlong HAC stem in the first 3 months after surgery, although subsidence in both groups thereafter plateaued, with minimal subsidence occurring in either group from 3 months to 5 years. Both stems displayed initial retroversion of the femoral implant in the first 3 months, but minor changes thereafter to 5 years. No stem in either group was considered loose. Clinical outcome was similar between the Furlong Active and HAC stem throughout the 5-year follow-up.

Como é que isto afectará o tratamento dos meus doentes?

Though subsidence of the Furlong Active stem was greater than that of the Furlong HAC stem, early migration did not appear to negatively impact 5-year outcome. Namely, osseointegration of the implant was observed to occur after 3 months, with minimal subsidence migration of either implant from 3 month to 5 years, and no loose components observed. Additionally, retroversion did not appear to substantial differ between stem designs. These findings suggest that similar results may be attained with the new Furlong Active stem relative the standard Furlong HAC stem, and that the new design modifications do not negatively affect integration of the component or clinical results. Nevertheless, additional research in a larger cohort of trials should be considered to confirm the the findings of the current study.

AVISO LEGAL

O conteúdo desta página destina-se apenas a fins informativos e não pretende substituir o aconselhamento, diagnóstico ou tratamento médico profissional. Se necessitar de tratamento médico, procure sempre o conselho do seu médico ou dirija-se ao serviço de urgência mais próximo. As opiniões, crenças e pontos de vista expressos pelos indivíduos no conteúdo encontrado nesta página não reflectem as opiniões, crenças e pontos de vista da OrthoEvidence.

0 de 4 artigos mensais GRATUITOS desbloqueados
Atingiu o seu limite de 4 visualizações de artigos gratuitos este mês

Aceda à OrthoEvidence por apenas $1,99 por semana.

Mantenha-se ligado às últimas evidências. Cancele a qualquer altura.
  • Avaliações críticas dos mais recentes ensaios clínicos aleatórios de alto impacto e revisões sistemáticas em ortopedia
  • Acesso ao conteúdo do podcast OrthoEvidence, incluindo colaborações com o Journal of Bone and Joint Surgery, entrevistas com cirurgiões reconhecidos internacionalmente e discussões em mesa redonda sobre notícias e tópicos ortopédicos
  • Subscrição do The Pulse, um boletim informativo duas vezes por semana baseado em evidências, concebido para o ajudar a tomar melhores decisões clínicas
Upgrade
Close Dialog
Bem-vindo de volta!
Esqueceu-se da palavra-passe?
Comece hoje o seu teste GRATUITO!

A sua conta será afiliada a
e inclui acesso gratuito ao OrthoEvidence


OU
Esqueceu-se da palavra-passe?

OU
Verifique o seu e-mail

Se existir uma conta com o endereço de e-mail fornecido, ser-lhe-á enviado um e-mail de reposição da palavra-passe. Se não vir uma mensagem de correio eletrónico, verifique a sua pasta de spam ou de lixo eletrónico.

Para obter mais assistência, contacte a nossa equipa de apoio.

Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Traduzir o Relatório ACE

A OrthoEvidence utiliza um serviço de tradução de terceiros para tornar o conteúdo acessível em vários idiomas. Tenha em atenção que, embora sejam feitos todos os esforços para garantir a exatidão, as traduções podem nem sempre ser perfeitas.

Como citar isto ACE Report

OrthoEvidence. Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years. OE Journal. 2015;3(6):29. Available from: https://myorthoevidence.com/AceReport/Show/despite-initial-migration-furlong-active-stem-comparable-to-furlong-hac-after-5-years

Copie a citação
Inicie sessão para ativar esta funcionalidade

Para aceder a esta funcionalidade, tem de iniciar sessão numa conta OrthoEvidence ativa. Inicie a sessão ou crie uma conta de avaliação GRATUITA.

Funcionalidade de Membro Premium

Para aceder a esta funcionalidade, tem de ter sessão iniciada numa conta Premium da OrthoEvidence.

Partilhe isto ACE Report